Hydroxyzine pamoate 25 MG Oral Capsule — RxCUI 995253
RxNorm drug concept · Semantic clinical drug
RxCUI 995253
Semantic clinical drug · SCD
● Current RxNorm concept 61 FDA products
167 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI995253
Official nameHydroxyzine pamoate 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped61
Package NDCs mapped167
Reported Medicaid activity (SDUD)2,601,531 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydroxyzine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Taken by mouth, it's used for anxiety and tension, itching from allergic skin conditions like hives and eczema, and sedation around anesthesia. The injection has additional uses in...
- It can. Drowsiness is the most common effect, though it often fades in a few days or with a lower dose. Don't drive or use dangerous machinery until you know how it affects you.
- It's best not to. Hydroxyzine can strengthen alcohol, narcotics, barbiturates and other sedating drugs. Tell your prescriber about everything you take, since doses of some may need...
- Can I drink alcohol or take other sedating medicines with it?
🕸️ Concept Web — How Hydroxyzine pamoate 25 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydroxyzine pamoate 25 MG Oral Capsule
RxCUI 995253 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hydroxyzine
5553IN -
Hydroxyzine pamoate
203182PIN
-
Hydroxyzine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vistaril
282519BN
-
Vistaril
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydroxyzine Oral Capsule
370662SCDF -
Hydroxyzine pamoate Oral Capsule
2649167SCDFP -
Hydroxyzine Oral Product
1164646SCDG -
Hydroxyzine Pill
1164647SCDG -
Hydroxyzine pamoate Oral Product
2660542SCDGP -
Hydroxyzine pamoate Pill
2659655SCDGP -
Hydroxyzine Oral Capsule [Vistaril]
366739SBDF -
Hydroxyzine pamoate Oral Capsule [Vistaril]
2656405SBDFP - +5 more in this family
-
Hydroxyzine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydroxyzine pamoate 25 MG
1484090SCDC -
Hydroxyzine pamoate 25 MG Oral Capsule [Vistaril]
995255SBD -
Hydroxyzine pamoate 25 MG [Vistaril]
1484093SBDC
-
Hydroxyzine pamoate 25 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydroxyzine pamoate 25 MG
SCDC · 1484090 -
Hydroxyzine Oral Capsule
SCDF · 370662 -
Hydroxyzine pamoate Oral Capsule
SCDFP · 2649167 -
Hydroxyzine Oral Product
SCDG · 1164646 -
Hydroxyzine Pill
SCDG · 1164647 -
Hydroxyzine pamoate Oral Product
SCDGP · 2660542 -
Hydroxyzine pamoate Pill
SCDGP · 2659655
Brand-Name Concepts
-
Hydroxyzine pamoate 25 MG Oral Capsule [Vistaril]
SBD · 995255 -
Hydroxyzine pamoate 25 MG [Vistaril]
SBDC · 1484093 -
Hydroxyzine Oral Capsule [Vistaril]
SBDF · 366739 -
Hydroxyzine pamoate Oral Capsule [Vistaril]
SBDFP · 2656405 -
Vistaril Oral Product
SBDG · 1187169 -
Vistaril Pill
SBDG · 1187171 -
Vistaril
BN · 282519
📦 FDA Products & Package NDCs
61 products · 167 package NDCs
167 package NDCs map to RxCUI 995253 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00115-1803-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0115-1803-01) | Hydroxyzine Pamoate | Amneal Pharmaceuticals of New York LLC | 1996-07-15 |
| 00115-1803-02 | 500 CAPSULE in 1 BOTTLE, PLASTIC (0115-1803-02) | Hydroxyzine Pamoate | Amneal Pharmaceuticals of New York LLC | 1996-07-15 |
| 00115-1804-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0115-1804-01) | Hydroxyzine Pamoate | Amneal Pharmaceuticals of New York LLC | 1996-06-15 |
| 00115-1804-02 | 500 CAPSULE in 1 BOTTLE, PLASTIC (0115-1804-02) | Hydroxyzine Pamoate | Amneal Pharmaceuticals of New York LLC | 1996-06-15 |
| 00185-0674-01 | 100 CAPSULE in 1 BOTTLE (0185-0674-01) | hydroxyzine pamoate | Sandoz Inc | 2014-06-27 |
| 00185-0674-05 | 500 CAPSULE in 1 BOTTLE (0185-0674-05) | hydroxyzine pamoate | Sandoz Inc | 2014-06-27 |
| 00185-0676-01 | 100 CAPSULE in 1 BOTTLE (0185-0676-01) | Hydroxyzine pamoate | Sandoz Inc | 2021-09-14 |
| 00185-0676-05 | 500 CAPSULE in 1 BOTTLE (0185-0676-05) | Hydroxyzine pamoate | Sandoz Inc | 2021-09-14 |
| 00555-0302-02 | 100 CAPSULE in 1 BOTTLE (0555-0302-02) | Hydroxyzine Pamoate | Teva Pharmaceuticals USA, Inc. | 1984-07-01 |
| 00555-0302-04 | 500 CAPSULE in 1 BOTTLE (0555-0302-04) | Hydroxyzine Pamoate | Teva Pharmaceuticals USA, Inc. | 1984-07-01 |
| 00555-0323-02 | 100 CAPSULE in 1 BOTTLE (0555-0323-02) | Hydroxyzine Pamoate | Teva Pharmaceuticals USA, Inc. | 1984-07-01 |
| 00555-0323-04 | 500 CAPSULE in 1 BOTTLE (0555-0323-04) | Hydroxyzine Pamoate | Teva Pharmaceuticals USA, Inc. | 1984-07-01 |
| 00555-0324-02 | 100 CAPSULE in 1 BOTTLE (0555-0324-02) | Hydroxyzine Pamoate | Teva Pharmaceuticals USA, Inc. | 1984-07-01 |
| 00615-8419-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8419-39) | Hydroxyzine Pamoate | NCS HealthCare of KY, LLC dba Vangard Labs | 2022-02-09 |
| 00615-8420-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8420-39) | Hydroxyzine Pamoate | NCS HealthCare of KY, LLC dba Vangard Labs | 2022-01-04 |
| 00904-7065-61 | 100 BLISTER PACK in 1 CARTON (0904-7065-61) / 1 CAPSULE in... | hydroxyzine pamoate | Major Pharmaceuticals | 2013-06-03 |
| 14539-0674-01 | 100 CAPSULE in 1 CONTAINER (14539-674-01) | hydroxyzine pamoate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2019-04-23 |
| 14539-0674-05 | 500 CAPSULE in 1 CONTAINER (14539-674-05) | hydroxyzine pamoate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2019-04-23 |
| 14539-0675-01 | 100 CAPSULE in 1 CONTAINER (14539-675-01) | hydroxyzine pamoate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2019-04-23 |
| 14539-0675-05 | 500 CAPSULE in 1 CONTAINER (14539-675-05) | hydroxyzine pamoate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2019-04-23 |
| 43063-0172-04 | 4 CAPSULE in 1 BOTTLE, PLASTIC (43063-172-04) | hydroxyzine pamoate | PD-Rx Pharmaceuticals, Inc. | 2014-06-28 |
| 43063-0406-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43063-406-01) | hydroxyzine pamoate | PD-Rx Pharmaceuticals, Inc. | 2014-07-01 |
| 43063-0406-10 | 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-406-10) | hydroxyzine pamoate | PD-Rx Pharmaceuticals, Inc. | 2014-07-01 |
| 43063-0406-15 | 15 CAPSULE in 1 BOTTLE, PLASTIC (43063-406-15) | hydroxyzine pamoate | PD-Rx Pharmaceuticals, Inc. | 2014-07-01 |
| 43063-0406-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-406-30) | hydroxyzine pamoate | PD-Rx Pharmaceuticals, Inc. | 2014-07-01 |
| 50090-4385-00 | 50 CAPSULE in 1 BOTTLE (50090-4385-0) | hydroxyzine pamoate | A-S Medication Solutions | 2019-06-25 |
| 50090-4385-02 | 20 CAPSULE in 1 BOTTLE (50090-4385-2) | hydroxyzine pamoate | A-S Medication Solutions | 2019-06-25 |
| 50090-4385-05 | 30 CAPSULE in 1 BOTTLE (50090-4385-5) | hydroxyzine pamoate | A-S Medication Solutions | 2019-06-25 |
| 50090-4579-02 | 20 CAPSULE in 1 BOTTLE (50090-4579-2) | Hydroxyzine Pamoate | A-S Medication Solutions | 2019-10-04 |
| 50090-4579-05 | 30 CAPSULE in 1 BOTTLE (50090-4579-5) | Hydroxyzine Pamoate | A-S Medication Solutions | 2019-10-04 |
| 50268-0398-50 | 50 BLISTER PACK in 1 BOX (50268-398-50) / 1 CAPSULE in 1 BL... | Hydroxyzine Pamoate | AvPAK | 2021-04-14 |
| 50268-0399-50 | 50 BLISTER PACK in 1 BOX (50268-399-50) / 1 CAPSULE in 1 BL... | Hydroxyzine Pamoate | AvPAK | 2021-04-14 |
| 51407-0001-01 | 100 CAPSULE in 1 CONTAINER (51407-001-01) | hydroxyzine pamoate | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0001-05 | 500 CAPSULE in 1 CONTAINER (51407-001-05) | hydroxyzine pamoate | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0002-01 | 100 CAPSULE in 1 CONTAINER (51407-002-01) | hydroxyzine pamoate | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0002-05 | 500 CAPSULE in 1 CONTAINER (51407-002-05) | hydroxyzine pamoate | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51655-0725-52 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-725-52) | hydroxyzine pamoate | Northwind Health Company, LLC | 2021-06-11 |
| 51655-0847-20 | 20 CAPSULE in 1 BOTTLE, PLASTIC (51655-847-20) | hydroxyzine pamoate | Northwind Health Company, LLC | 2023-04-10 |
| 51655-0847-52 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-847-52) | hydroxyzine pamoate | Northwind Health Company, LLC | 2023-05-03 |
| 55154-2337-00 | 10 BLISTER PACK in 1 BAG (55154-2337-0) / 1 CAPSULE in 1 BL... | hydroxyzine pamoate | Cardinal Health 107, LLC | 2013-06-03 |
| 60687-0696-01 | 100 BLISTER PACK in 1 CARTON (60687-696-01) / 1 CAPSULE in... | Hydroxyzine Pamoate | American Health Packaging | 2023-11-28 |
| 60687-0707-01 | 100 BLISTER PACK in 1 CARTON (60687-707-01) / 1 CAPSULE in... | Hydroxyzine Pamoate | American Health Packaging | 2023-05-24 |
| 60687-0707-65 | 50 BLISTER PACK in 1 CARTON (60687-707-65) / 1 CAPSULE in 1... | Hydroxyzine Pamoate | American Health Packaging | 2023-12-21 |
| 61919-0880-15 | 15 CAPSULE in 1 BOTTLE (61919-880-15) | Hydroxyzine Pamoate | Direct_Rx | 2019-06-03 |
| 61919-0880-30 | 30 CAPSULE in 1 BOTTLE (61919-880-30) | Hydroxyzine Pamoate | Direct_Rx | 2019-06-03 |
| 61919-0880-60 | 60 CAPSULE in 1 BOTTLE (61919-880-60) | Hydroxyzine Pamoate | Direct_Rx | 2019-06-03 |
| 62135-0816-12 | 120 CAPSULE in 1 BOTTLE (62135-816-12) | Hydroxyzine pamoate | Chartwell RX, LLC | 2024-02-06 |
| 62135-0817-12 | 120 CAPSULE in 1 BOTTLE (62135-817-12) | Hydroxyzine pamoate | Chartwell RX, LLC | 2024-02-06 |
| 63629-8874-01 | 500 CAPSULE in 1 BOTTLE (63629-8874-1) | hydroxyzine pamoate | Bryant Ranch Prepack | 2014-06-27 |
| 63629-9612-01 | 100 CAPSULE in 1 BOTTLE (63629-9612-1) | hydroxyzine pamoate | Bryant Ranch Prepack | 2023-01-23 |
Observed labelers:
Bryant Ranch Prepack (41) ·
Aphena Pharma Solutions - Tennessee, LLC (20) ·
Proficient Rx LP (19) ·
Asclemed USA, Inc. (14) ·
NuCare Pharmaceuticals,Inc. (6) ·
A-S Medication Solutions (5)
· +21 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.